
Test detects breast cancer in earliest stage
The new research results were presented at the 2019 NCRI Cancer Conference today by Daniyah Alfattani from National Cancer Research Institute (NCRI)...

BioVersys receives up to €8m from CARB-X
Privately-owned BioVersys AG, headquartered in Basel, is focusing on research and development of small molecules for multidrug-resistant bacterial...

Protein protects against liver fibrosis
In mice, a team headed by Philipp Lang from University Düsseldorf, Germany, showed that the iRhom2 protein counteracted the injury- and...

Novo Nordisk enters haemophilia gene therapy field
Changes in the treatment standard of haemophilia A, such as Roche’s 2017 launch of Hemlibra, have put Novo Nordisk’s revenues (in the US$15.8bn...

NSCLC: Bemcentinib + anti-PD1 triple PFS
Bergen Bio ASA announced the primary endpoint of 25% Overall Response Rate (ORR) has been met in predominantly PD-L1 negative/low NSCLC patients in a...

GHO capital launches EU's largest fund ever for life sciences
Global Healthcare Opportunities, or GHO Capital Partners LLP said that its finally closed Fund II will be focussed on high growth healthcare...

EU with poor success in fighting superbugs
Although some progress has been made through EU action, there is little evidence so far to suggest that the health burden of antimicrobial resistance...